Silexion Therapeutics Other Current Liabilities

As of the most recent data (June 2026), SLXN shows a other current liabilities of $1.6M. That compares with $1.3M in the prior-year period — up 26.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLXN's other current liabilities is now $1.6M (was $1.3M) — a 26.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Silexion Therapeutics is outperforming or lagging.

Tracking SLXN's other current liabilities over time shows whether Silexion Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6M That compares with $1.3M in the prior-year period — up 26.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Silexion Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.6M) with ownership activity and broader fundamentals.